Barbara Weiland - Merck KGaA Chief Officer
| MKKGY Stock | USD 29.53 0.45 1.55% |
Insider
Barbara Weiland is Chief Officer of Merck KGaA ADR
| Age | 49 |
| Phone | 49 6151 72 0 |
| Web | https://www.merckgroup.com |
Merck KGaA Management Efficiency
The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck KGaA's management efficiency ratios could be used to measure how well Merck KGaA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Sen | Fresenius SE Co | 55 | |
| Peter Guenter | MERCK Kommanditgesellschaft auf | 61 | |
| Sara Hennicken | Fresenius SE Co | 43 | |
| Dirk Toepfer | MERCK Kommanditgesellschaft auf | N/A | |
| KokKien Loh | Straumann Holding AG | 56 | |
| Carla Kriwet | Fresenius SE Co | 51 | |
| Gerhard Schmitz | MERCK Kommanditgesellschaft auf | 60 | |
| Aurelio Sahagun | Straumann Holding AG | 50 | |
| Alon Halevy | Recruit Holdings Co | N/A | |
| Friederike Rotsch | MERCK Kommanditgesellschaft auf | 51 | |
| Graeme Maude | Recruit Holdings Co | 56 | |
| Sebastian Biedenkopf | Fresenius SE Co | 59 | |
| Akihiko Mori | Recruit Holdings Co | N/A | |
| Belen MD | MERCK Kommanditgesellschaft auf | 63 | |
| Matthias Link | Fresenius SE Co | N/A | |
| Rahma Samow | Straumann Holding AG | 44 | |
| Holger Haderer | Straumann Holding AG | 54 | |
| Kiyoaki Idemitsu | Ono Pharmaceutical Co | 59 | |
| Helen Giza | Fresenius SE Co | 55 | |
| Alastair Robertson | Straumann Holding AG | 63 | |
| Camila Finzi | Straumann Holding AG | 51 | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 |
Merck KGaA ADR Leadership Team
Elected by the shareholders, the Merck KGaA's board of directors comprises two types of representatives: Merck KGaA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck KGaA's management team and ensure that shareholders' interests are well served. Merck KGaA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck KGaA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthias Heinzel, CEO Board | ||
| Peter Guenter, CEO Board | ||
| Barbara Weiland, Chief Officer | ||
| Dirk Toepfer, Chief Officer | ||
| Gerhard Schmitz, Head Accounting | ||
| Belen MD, Chair CEO | ||
| Kai Beckmann, Chief Administrative Officer, Member of the Executive Board | ||
| Marcus Kuhnert, Member of the Executive Board, CFO | ||
| Constantin Fest, Head of Investor Relations | ||
| Friederike Rotsch, Group Compliance |
Merck Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Merck KGaA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 92.22 B | |||
| Shares Outstanding | 2.17 B | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 33.17 X | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 3.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Merck Pink Sheet Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.